one A load estimated at about one million dollars in Mountrao drugsDiabetes treatment and use of weight loss have been indicated in a procedure from the Federal Police at Risive International Airport in Dawn on Sunday (13).
About 389 pens were intercepted by the drug by boycotting revenues during risk analysis and passenger control. The member has determined that the traveler coming from the UK carried drugs irregularly.
The inspection was conducted at the time of the passenger’s arrival, as part of the customs control routine. This work is part of activities aimed at combating smuggling and misleading crimes.
What is Mongro
It will be mounjaro, diabetes in Eli Lilly, available in the Brazilian market From June 7.
The main competitor of OzemPIC and Wegovy, both of them from the new Danish pharmacist Nordisk, the drug consists of the Thebatet, a dual-raised molecule of GLP-1 and GIP, and hormones created in the intestine and released after meals, and increased insulin production by knights to control sugar in the blood.
Mountrao was approved by the National Health Control Agency (AnVisa) in Brazil in September 2023 to treat type 2 diabetes.
There are already other drugs in Brazil of the same chapter, however Mounjaro has a different mechanismBecause it is not just a rush, that is, it does not only work on the GLP-1 reception, but it also works on the GIP reception. “It is the only medicine for this group that works on these two receptions,” said Louise Magno, first medical director of Layla de Brazil, to CNN.
According to Tassyane Alvarenga, the endocrine scientist and a USP metabolic specialist (University of São Paulo), GIP and GLP-1 are associated with greater insulin secretion, but studies lead to the belief that GIP responds for two-thirds of this contribution. This makes Tirzepatida stronger than semaglutado, found in OzemPic.
“Mounjaro urges a feeling of satiety, that is, time between eating and contentment. It is a permanent effect of anorexia, which is the main feature of OzPic,” explains the endocrinologist.
The medicine must be It is used in the treatment of diabetes Associated with lifestyle changes, such as adopting healthy eating and practicing physical activity. Remember that Mounjaro was not approved to treat obesity And yes, only for type 2 diabetes.
The value of the drug may vary depending on the tax on the trading of goods and the provision of services (ICMS) in each state, the dose and the number of pens for the application for each package. For example, in Sao Paulo, the maximum dose may cost $ 3,791.07.
Side effects
According to a study published in the New England Medicine Journal, it was shown that both Terzepata and Smaglott It has similar side effectsBut the effects of the first molecule can be more numerous and more dangerous. According to work, mounjaro can cause severe digestive diseases. In clinical trials, more people have stopped taking the medicine due to intestinal side effects.
Both medications can cause symptoms such as abdominal pain, constipation, diarrhea, nausea and vomiting. Tirzepatida can cause indigestion.
For this reason, It is necessary to request medical advice before starting treatmentBoth with ozepic, with Mongoro.
*Under supervision
